BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33307252)

  • 1. Mass spectrometry-based proteomic exploration of the small urinary extracellular vesicles in ANCA-associated vasculitis in comparison with total urine.
    Prikryl P; Satrapova V; Frydlova J; Hruskova Z; Zima T; Tesar V; Vokurka M
    J Proteomics; 2021 Feb; 233():104067. PubMed ID: 33307252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics combined with clinical analysis explores metabolic changes and potential serum metabolite biomarkers of antineutrophil cytoplasmic antibody-associated vasculitis with renal impairment.
    Liu S; Xu Q; Wang Y; Lv Y; Liu QQ
    PeerJ; 2023; 11():e15051. PubMed ID: 36942002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis.
    Moran SM; Scott J; Clarkson MR; Conlon N; Dunne J; Griffin MD; Griffin TP; Groarke E; Holian J; Judge C; Wyse J; McLoughlin K; O'Hara PV; Kretzler M; Little MA;
    J Am Soc Nephrol; 2021 Nov; 32(11):2920-2932. PubMed ID: 34518279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis.
    Frydlova J; Zednikova I; Satrapova V; Pazourkova E; Santorova S; Hruskova Z; Tesar V; Vokurka M; Prikryl P; Korabecna M
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Haubitz M; Good DM; Woywodt A; Haller H; Rupprecht H; Theodorescu D; Dakna M; Coon JJ; Mischak H
    Mol Cell Proteomics; 2009 Oct; 8(10):2296-307. PubMed ID: 19564150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a 'liquid gold' biopsy.
    Hallal SM; Tűzesi Á; Sida LA; Xian E; Madani D; Muralidharan K; Shivalingam B; Buckland ME; Satgunaseelan L; Alexander KL
    Br J Cancer; 2024 Mar; 130(5):836-851. PubMed ID: 38212481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid Isolation of Extracellular Vesicles from Blood Plasma with Size-Exclusion Chromatography Followed by Mass Spectrometry-Based Proteomic Profiling.
    Kreimer S; Ivanov AR
    Methods Mol Biol; 2017; 1660():295-302. PubMed ID: 28828666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
    Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
    J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
    An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
    Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Robust and Clinically Applicable Sample Preparation Protocol for Urinary Extracellular Vesicle Isolation Suitable for Mass Spectrometry-Based Proteomics.
    Erozenci LA; Bijnsdorp IV; Piersma SR; Jimenez CR
    Methods Mol Biol; 2023; 2718():235-251. PubMed ID: 37665463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity.
    Lardinois OM; Deterding LJ; Hess JJ; Poulton CJ; Henderson CD; Jennette JC; Nachman PH; Falk RJ
    PLoS One; 2019; 14(2):e0213215. PubMed ID: 30818380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
    Puhka M; Takatalo M; Nordberg ME; Valkonen S; Nandania J; Aatonen M; Yliperttula M; Laitinen S; Velagapudi V; Mirtti T; Kallioniemi O; Rannikko A; Siljander PR; Af Hällström TM
    Theranostics; 2017; 7(16):3824-3841. PubMed ID: 29109780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.
    Kim SM; Choi SY; Kim SY; Kim J
    Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Profile of Procoagulant Extracellular Vesicles Reflects Complement System Activation and Platelet Hyperreactivity of Patients with Severe COVID-19.
    Moraes ECDS; Martins-Gonçalves R; da Silva LR; Mandacaru SC; Melo RM; Azevedo-Quintanilha I; Perales J; Bozza FA; Souza TML; Castro-Faria-Neto HC; Hottz ED; Bozza PT; Trugilho MRO
    Front Cell Infect Microbiol; 2022; 12():926352. PubMed ID: 35937696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
    Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
    Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
    Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO
    Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential saliva and tear biomarkers in primary Sjögren's syndrome, utilising the extraction of extracellular vesicles and proteomics analysis.
    Aqrawi LA; Galtung HK; Vestad B; Øvstebø R; Thiede B; Rusthen S; Young A; Guerreiro EM; Utheim TP; Chen X; Utheim ØA; Palm Ø; Jensen JL
    Arthritis Res Ther; 2017 Jan; 19(1):14. PubMed ID: 28122643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.